We have built up an exciting portfolio of investments in high potential businesses across a range of therapeutic areas, technologies, geographies and clinical contexts.
30 November 2017
Epic Sciences, Inc. announces the release of its breast cancer single-cell profiling panel. The Epic breast cancer panel is the most comprehensive breast cancer biomarker panel available for characterization of circulating tumor cells (CTCs) within a blood sample.
28 November 2017
ReVision Optics, Inc. (RVO), a leader in implantable presbyopia-correcting corneal inlay technology, announces that its Raindrop® Near Vision Inlay for presbyopia was featured in multiple scientific presentations and instructional courses at the annual meeting of the American Academy of Ophthalmology (AAO) held November 11-14 in New Orleans. The presentations highlighted study data focusing on key attributes to improve clinical outcomes with the Raindrop procedure.